The Street, of course, anticipates hostile bidder F. Hoffmann-La Roche Ltd. will ultimately pony up greater takeover riches for $3 billion market cap Ventana Medical Systems Inc. But the Basel, Switzerland-based pharmaceutical giant is, by all accounts, very patient and may prove the market wrong in the end, at least in terms of the amount of a bump.
To read the entire story, you must be logged in.
Please log in now or register with us.
